Grace Capital’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,000
Closed -$235K 166
2021
Q2
$235K Hold
3,000
0.16% 124
2021
Q1
$171K Hold
3,000
0.11% 157
2020
Q4
$251K Buy
+3,000
New +$251K 0.16% 135